Inflammatory bowel disease Clinical Trials in Portland, ME
As of June 2026, 1 paid clinical trial is recruiting for Inflammatory bowel disease in Portland, Maine. Inflammatory bowel disease studies test biologics, S1P modulators, and JAK inhibitors for ulcerative colitis and Crohn's disease. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
1 clinical trial for Inflammatory bowel disease
·Clear filters·↓ Download CSVAbout research studies in Portland
Portland has approximately 79 recruiting research studies across a wide range of therapeutic areas. Maine hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Portland
Researchers run research studies in Portland, ME at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| MaineHealth Maine Medical Center - Portland | Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy | 25 |
| Maine Medical Center | Atrial Fibrillation, ADHD, Abdominal Aortic Aneurysm | 21 |
| MaineHealth | Aging, Alzheimer Disease, Aneurysmal Subarachnoid Hemorrhage (aSAH) | 4 |
| Maine Eye Center | Geographic Atrophy, Macular Degeneration, Neovascular Age-Related Macular Degeneration | 3 |
| Maine Medical Partners Pediatric Specialty Care | Cerebroside Lipidosis Syndrome, Fabry Disease, Gaucher Disease | 3 |
| Maine Health | Cancer, Irritable Bowel Syndrome With Constipation (IBS-C), Myocarditis Acute | 2 |
| MaineHealth Maine Medical Center | Burn (Disorder), Burn Degree Second, Burns Degree Third | 2 |
| Portland Gastroenterology Center | Celiac Disease, Crohn's Disease, Ulcerative Colitis | 2 |
| Maine Eye Center - Marginal Way Campus | AMD, CNV, Wet Age-related Macular Degeneration | 2 |
| East End Community Center | Advance Care Planning, Advance Directives, Chronic Illness | 1 |
| GSK Investigational Site | Multiple Myeloma, Newly Diagnosed Multiple Myeloma | 1 |
| Maine Health - Maine Medical Center | Homocystinuria | 1 |
| Maine Health Pediatric Specialty Care | Homocystinuria | 1 |
| Maine Medical | Aortic Aneurysm, Abdominal | 1 |
| Maine Medical Center - Division of Pulmonary and Critical Care Medicine | Cystic Fibrosis (CF), Exocrine Pancreatic Insufficiency (EPI), Pancreatic Diseases | 1 |
| Maine Medical Center Bramhall | Acute Myocardial Infarction (AMI), Cardiovascular Risk | 1 |
| Maine Medical Center-Bramhall Campus | Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 | 1 |
| Maine Medical Centre | Community-acquired Pneumonia | 1 |
| Maine Medical Partners | Colitis, Ulcerative | 1 |
| Maine Medical Partners Surgical Care | Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Ann Arbor Stage I Lymphoma | 1 |
| MaineHealth Maine Medical Center Portland | Interprofessional Education, Neonatal Resuscitation, Rural Health | 1 |
| MaineHealth Pediatric Specialty Care | Cystic Fibrosis (CF), Exocrine Pancreatic Insufficiency (EPI) | 1 |
| Northern Light Breast Care | Breast Cancer | 1 |
| Ovation.io | Cancer, Other Disease | 1 |
| The Vascular Care Group | PAD, Peripheral Artery Calcification, Peripheral Artery Disease | 1 |
Active & Upcoming Studies in Portland (2026)
Recruiting trials in Portland grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (29 active studies)
- Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer · Phase 3 · National Cancer Institute (NCI)
- Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer · Phase 3 · NRG Oncology
Cardiovascular (8 active studies)
- CTSN Embolic Protection Trial · Icahn School of Medicine at Mount Sinai
- Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery · Unity Health Toronto
Eye & vision (5 active studies)
- Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) · Phase 3 · AbbVie
- A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) · Phase 2 · Janssen Research & Development, LLC
Neurology & pain (3 active studies)
- Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders · University of Michigan
- CTSN Embolic Protection Trial · Icahn School of Medicine at Mount Sinai
Pediatric (2 active studies)
- Comparative Study of Simulation Technologies for Use in Neonatal Resuscitation Training for Rural Hospitals · MaineHealth
- Supraglottic Airway for Resuscitation Trial · Children's Hospital of Philadelphia
Diabetes & metabolic (1 active study)
Common conditions studied in Portland
- Acute Myeloid Leukemia (6 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm (2 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Acute Myeloid Leukemia Post Cytotoxic Therapy (2 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Acute Myeloid Leukemia, Myelodysplasia-Related (2 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Atrial Fibrillation (2 active studies). Atrial fibrillation studies investigate next-generation anticoagulants, ablation technologies, and left atrial appendage closure devices.
- Breast Cancer (2 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
Leading research sponsors in Portland
- National Cancer Institute (NCI)
- NRG Oncology
- Genzyme, a Sanofi Company
- MaineHealth
- AbbVie
Local regulations and guidelines
Clinical trials in Maine are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Maine research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Portland. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Portland
Hipa.ai aggregates every recruiting study in Portland from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Portland?
There are approximately 79 recruiting clinical trials in Portland, Maine listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Portland pay participants?
Most recruiting trials in Portland compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Portland?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Portland?
The most common conditions under active study in Portland include Acute Myeloid Leukemia (6), Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm (2), Acute Myeloid Leukemia Post Cytotoxic Therapy (2), Acute Myeloid Leukemia, Myelodysplasia-Related (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Portland?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Portland on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Portland?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Portland?
Recruiting research sites in Portland include MaineHealth Maine Medical Center - Portland, Maine Medical Center, MaineHealth, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Portland right now?
The largest active categories in Portland are Cancer & tumors (29), Cardiovascular (8), Eye & vision (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.